GLP-1 drugs like Ozempic and Zepbound already rewrote the obesity playbook, but 2026 is shaping up as the sequel nobody saw coming: goodbye weekly shots, hello daily pills — and hello drugs that hit three hunger hormones at once for potentially double the drop.   Orforglipron (Lilly's oral conten...